- 1 سال پیش
- 578
- 06:21
ACC.24 Congress Coverage: Safety and Efficacy of Ninerafaxstat in Patients With Nonobstructive HCM
Daily cardiology
0
Avatar
کاربر شنوتواولین نفر کامنت بزار
ACC.24: RELIEVE-HF trial...
ACC.24: RELIEVE-HF trial
05:57
- 480
- 1 سال پیش
05:57
- 503
- 1 سال پیش
ACC.24: REDUCE-IT trial - Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl...
ACC.24: REDUCE-IT trial - Lipoprotein(a) Blood...
06:28
- 503
- 1 سال پیش
06:28
ACC.24: VICTORION-INITIATE trial - An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease...
ACC.24: VICTORION-INITIATE trial - An “Inclisi...
05:15
- 492
- 1 سال پیش
05:15
- 545
- 1 سال پیش
ACC.24: BE ACTIVE Trial - Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events...
ACC.24: BE ACTIVE Trial - Effect of Gamificati...
04:13
- 545
- 1 سال پیش
04:13
- 531
- 1 سال پیش
ACC.24: TACTiC Trial...
ACC.24: TACTiC Trial
07:00
- 531
- 1 سال پیش
07:00
- 552
- 1 سال پیش
Infarction ACC.24: AEGIS-II Trial...
Infarction ACC.24: AEGIS-II Trial
05:15
- 552
- 1 سال پیش
05:15
ACC.24 Congress Coverage: Trial of a Selective Aldose Reductase Inhibitor in Diabetic Cardiomyopathy
- 513
- 1 سال پیش
ACC.24: ARISE-HF Trial...
ACC.24: ARISE-HF Trial
02:49
- 513
- 1 سال پیش
02:49
ACC.24: SGLT2i in ACHD...
ACC.24: SGLT2i in ACHD
06:37
- 517
- 1 سال پیش
06:37
ACC.24 Congress Coverage: Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
- 590
- 1 سال پیش
ACC.24: Bridge TIMI 73a Trial...
ACC.24: Bridge TIMI 73a Trial
05:32
- 590
- 1 سال پیش
05:32
تمامی حقوق این وبسایت متعلق به شنوتو است